Immatics N.V. (IMTX) Financials

IMTX Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 554.1 million 98.2 million
March 31, 2026 623.2 million 100.3 million
Dec. 31, 2025 660.2 million 91.8 million
Sept. 30, 2025 608.5 million 119.6 million

IMTX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -70.8 million ?
March 31, 2026 -49.9 million 6.8 million
Dec. 31, 2025 -68.8 million 3.9 million
Sept. 30, 2025 -53.7 million 3.8 million

IMTX Net Income

No data available :(

IMTX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 448.7 million - 13.6 million
March 31, 2026 520.3 million - 17.3 million
Dec. 31, 2025 551.0 million - 18.4 million
Sept. 30, 2025 505.6 million - 19.2 million

IMTX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 156.0 million
March 31, 2026 154.3 million
Dec. 31, 2025 148.0 million
Sept. 30, 2025 142.7 million

IMTX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 1.0 million 72.4 million 12.7 million -
March 31, 2026 888743 67.8 million 16.6 million -
Dec. 31, 2025 1.1 million 58.3 million 16.0 million -
Sept. 30, 2025 1.3 million 55.4 million 14.9 million -

IMTX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 10.6 million -
March 31, 2026 8.7 million -
Dec. 31, 2025 23.2 million -
Sept. 30, 2025 6.1 million -

IMTX

Price: $6.72

52 week price:
6.72
12.41

Earnings Per Share: -1.98 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: Germany

Volume: 207152

Market Capitalization: 1.0 billion

Links: